Cilostazol
- 2 independent labs in 2 countries
- 2 trials, none about aging
- Funder: National Institute for Health and Care Research
- Animals2
Outcomes
2Inflammation
downin mice1
1 study
Inflammation
downin mice1
Cilostazol decreases inflammation in mice.
“Cilostazol as a new STING inhibitor that attenuates aging-related endothelial inflammation both in vitro and in vivo”
Animalsaging-related
Acta pharmacologica SinicaApr 30, 2024
Vasodilation
upin rats1
1 study
Vasodilation
upin rats1
Cilostazol improves vasodilation in rats.
“pretreatment of aortas with cilostazol enhanced the potency of atorvastatin in both young and adult aortas.”
Animalsprecontracted with phenylephrinethoracic aorta rings10−6 Mfemales
Cilostazol enhances atorvastatin-induced vasodilation of female rat aorta during aging
Physiology internationalSep 1, 2017
Trial sponsors
1 trialPhase 32,000 people
National Institute of Allergy and Infectious Diseases
1 trialPhase 1/2250 people
Funding
1 grant since 2025National Institute for Health and Care Research£2.7m
Latest
Acta Pharmacologica Sinica
Cytosolic DNA initiates a vicious circle of aging-related endothelial inflammation and mitochondrial dysfunction via STING: the inhibitory effect of Cilostazol
Experiments in miceInterventions
Molecular Neurobiology
PDE3 Inhibitors Repurposed as Treatments for Age-Related Cognitive Impairment
ReviewInterventions
European Journal of Pharmacology
Phosphodiesterase-3 inhibitor cilostazol reverses endothelial dysfunction with ageing in rat mesenteric resistance arteries
Experiments in animalsInterventions
Neuropharmacology
Long-term cilostazol administration prevents age-related decline of hippocampus-dependent memory in mice
Experiments in animalsInterventions
Physiology International
Cilostazol enhances atorvastatin-induced vasodilation of female rat aorta during aging
Experiments in animalsMechanisms